Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin–tazobactam

Bone Marrow Transplantation volume 36, pages 59–65 (2005)Cite this article

Summary:

The safety and efficacy of early bacterial prophylaxis with piperacillin–tazobactam were prospectively evaluated in 51 autologous peripheral blood stem cell transplantation (PBSCT) recipients. The results were compared with those obtained in 51 control patients receiving oral fluoroquinolones in a retrospective matched-pair control study. Overall, 76% of the study group and 98% of the control group developed at least one febrile episode during neutropenia (P=0.002). Time from neutropenia to the first febrile episode (FFE) was significantly longer in the study group than in the control group (P=0.04). Once a febrile episode appeared, the duration of fever was significantly longer in cases than in controls (median of 5 and 2 days respectively, P<0.001), and led to a more frequent use of empirical amphotericin B (AmB), not statistically significant (P=0.13). However, the total time of antibiotic administration was significantly greater in the control than in the study group (P=0.05). The duration of AmB treatment shows a trend toward a longer duration in the control than in study group (P=0.2). Overall, 86% of the Gram-positive bacteremia and 85% of the Gram-negative bacteria were susceptible to the tested antibiotics. Our study suggests that a subgroup of patients could benefit from prophylaxis with piperacillin–tazobactam without increasing toxicity or bacterial resistance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Engels EA, Ellis CA, Supran SE et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256–266.

    Article  CAS  Google Scholar 

  2. Kruger W, Russmann B, Kroger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases. Bone Marrow Transplant 1999; 23: 589–597.

    Article  CAS  Google Scholar 

  3. Barton T, Collis T, Stadtmauer E, Schuster M . Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin Infect Dis 2001; 32: 391–395.

    Article  CAS  Google Scholar 

  4. Saavedra S, Jarque I, Sanz GF et al. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin Microbiol Infect 2002; 8: 725–733.

    Article  CAS  Google Scholar 

  5. Buzyn A, Tancrede C, Nitenberg G, Cordonnier C . Reflections on gut decontamination in hematology. Clin Microbiol Infect 1999; 5: 449–456.

    Article  Google Scholar 

  6. Kerr KG . The prophylaxis of bacterial infections in neutropenic patients. J Antimicrobial Chemother 1999; 44: 587–591.

    Article  CAS  Google Scholar 

  7. Sepkowitz KA . Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant. Bone Marrow Transplant 2002; 29: 367–371.

    Article  CAS  Google Scholar 

  8. Cruciani M, Rampazzo R, Malena M et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 1996; 23: 795–805.

    Article  CAS  Google Scholar 

  9. Horvathova Z, Spanik S, Sufliarsky J et al. Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia. Int J Antimicrobial Agents 1998; 10: 55–58.

    Article  CAS  Google Scholar 

  10. Elting LS, Bodey GP, Keefe BH . Septicemia and shock syndrome due to viridans streptococci: a case–control study of predisposing factors. Clin Infect Dis 1992; 14: 1201–1207.

    Article  CAS  Google Scholar 

  11. Tunkel AR, Sepkowitz KA . Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002; 34: 1524–1529.

    Article  Google Scholar 

  12. Yeh SP, Hsueh EJ, Yu MS et al. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal. Bone Marrow Transplant 1999; 24: 1207–1211.

    Article  CAS  Google Scholar 

  13. van Kraaij MG, Dekker AW, Peters E et al. Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients. Eur J Clin Microbiol Infect Dis 1998; 17: 591–592.

    Article  CAS  Google Scholar 

  14. Oethinger M, Conrad S, Kaifel K et al. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrobial Agents Chemother 1996; 40: 387–392.

    Article  CAS  Google Scholar 

  15. Baum HV, Franz U, Geiss HK . Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients. Infection 2000; 28: 278–281.

    Article  CAS  Google Scholar 

  16. Avril M, Hartmann O, Valteau-Couanet D et al. Antiinfective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation. Pediatr Hematol Oncol 1994; 11: 63–73.

    Article  CAS  Google Scholar 

  17. Kroschinsky F, Wichmann G, Bornhauser M et al. Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation. Transpl Infect Dis 2002; 4: 132–136.

    Article  CAS  Google Scholar 

  18. Meisenberg B, Gollard R, Brehm T et al. Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue. Support Care Cancer 1996; 4: 364–369.

    Article  CAS  Google Scholar 

  19. National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard, 5th edn. Clinical and Laboratory Standards Institute: Wayne, PA, 2000 (http://www.nccls.org).

  20. Bauernfeind A, Abele-Horn M, Emmerling P, Jungwirth R . Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrobial Chemother 1994; 34: 1074–1076.

    Article  CAS  Google Scholar 

  21. Sanders CC, Sanders Jr WE, Goering RV, Werner V . Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrobial Agents Chemother 1984; 26: 797–801.

    Article  CAS  Google Scholar 

  22. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–751.

    Article  Google Scholar 

  23. Karp JE, Dick JD, Angelopulos C et al. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med 1986; 81: 237–242.

    Article  CAS  Google Scholar 

  24. Petersen F, Thornquist M, Buckner C et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 1988; 16: 199–208.

    Article  CAS  Google Scholar 

  25. Jagannath S, Vesole DH, Zhang M et al. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplant 1997; 20: 445–450.

    Article  CAS  Google Scholar 

  26. Meisenberg BR, Ferran K, Hollenbach K et al. Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplant 1998; 21: 927–932.

    Article  CAS  Google Scholar 

  27. Chandrasekar PH, Abraham OC, Klein J et al. Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer. Clin Infect Dis 2001; 32: 546–551.

    Article  CAS  Google Scholar 

  28. Rovira M . Outpatient management of autologous haematopoietic cell transplantation: the Barcelona experience. Presse Med 2004; 33: 479–481.

    Article  Google Scholar 

  29. Sanz MA, Lopez J, Lahuerta JJ et al. Cefepime plus amikacin versus piperacillin–tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. J Antimicrobial Chemother 2002; 50: 79–88.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology and Medical Oncology, University Clinic Hospital, School of Medicine, University of Valencia, Valencia, Spain

    C Solano, A Gutierrez, C Gómez & R Goterris

  2. Department of Statistics, University of Valencia, Valencia, Spain

    F Martinez

  3. Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain

    C Gimeno, I Muñoz, A Farga & D Navarro

  4. School of Nursing, University of Valencia, Valencia, Spain

    F Faus

Authors
  1. C Solano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Gutierrez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Gimeno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I Muñoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F Faus
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R Goterris
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Farga
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. D Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Solano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solano, C., Gutierrez, A., Martinez, F. et al. Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin–tazobactam. Bone Marrow Transplant 36, 59–65 (2005). https://doi.org/10.1038/sj.bmt.1705005

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705005

Keywords

This article is cited by

Search

Advanced search

Quick links